• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Avient Corporation

    5/7/24 1:01:03 PM ET
    $AVNT
    Major Chemicals
    Industrials
    Get the next $AVNT alert in real time by email
    avnt-20240331
    0001122976false2024Q112/31http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent00011229762024-01-012024-03-3100011229762024-03-31xbrli:sharesiso4217:USD00011229762023-01-012023-03-31iso4217:USDxbrli:shares00011229762023-12-3100011229762022-12-3100011229762023-03-310001122976us-gaap:CommonStockMember2023-12-310001122976us-gaap:TreasuryStockCommonMember2023-12-310001122976us-gaap:AdditionalPaidInCapitalMember2023-12-310001122976us-gaap:RetainedEarningsMember2023-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001122976us-gaap:ParentMember2023-12-310001122976us-gaap:NoncontrollingInterestMember2023-12-310001122976us-gaap:RetainedEarningsMember2024-01-012024-03-310001122976us-gaap:ParentMember2024-01-012024-03-310001122976us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001122976us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001122976us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001122976us-gaap:CommonStockMember2024-03-310001122976us-gaap:TreasuryStockCommonMember2024-03-310001122976us-gaap:AdditionalPaidInCapitalMember2024-03-310001122976us-gaap:RetainedEarningsMember2024-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001122976us-gaap:ParentMember2024-03-310001122976us-gaap:NoncontrollingInterestMember2024-03-310001122976us-gaap:CommonStockMember2022-12-310001122976us-gaap:TreasuryStockCommonMember2022-12-310001122976us-gaap:AdditionalPaidInCapitalMember2022-12-310001122976us-gaap:RetainedEarningsMember2022-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001122976us-gaap:ParentMember2022-12-310001122976us-gaap:NoncontrollingInterestMember2022-12-310001122976us-gaap:RetainedEarningsMember2023-01-012023-03-310001122976us-gaap:ParentMember2023-01-012023-03-310001122976us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001122976us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001122976us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001122976us-gaap:CommonStockMember2023-03-310001122976us-gaap:TreasuryStockCommonMember2023-03-310001122976us-gaap:AdditionalPaidInCapitalMember2023-03-310001122976us-gaap:RetainedEarningsMember2023-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001122976us-gaap:ParentMember2023-03-310001122976us-gaap:NoncontrollingInterestMember2023-03-310001122976avnt:SpecialtyEngineeredMaterialsMember2023-12-310001122976avnt:ColorAdditivesAndInksMember2023-12-310001122976avnt:SpecialtyEngineeredMaterialsMember2024-01-012024-03-310001122976avnt:ColorAdditivesAndInksMember2024-01-012024-03-310001122976avnt:SpecialtyEngineeredMaterialsMember2024-03-310001122976avnt:ColorAdditivesAndInksMember2024-03-310001122976us-gaap:CustomerRelationshipsMember2024-03-310001122976avnt:PatentsTechnologyAndOtherMember2024-03-310001122976us-gaap:TradeNamesMember2024-03-310001122976us-gaap:CustomerRelationshipsMember2023-12-310001122976avnt:PatentsTechnologyAndOtherMember2023-12-310001122976us-gaap:TradeNamesMember2023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-01-012024-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:WorkforceReductionsMember2022-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:PlantClosingAndOtherMember2022-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2022-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:WorkforceReductionsMember2023-01-012023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:PlantClosingAndOtherMember2023-01-012023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-01-012023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:WorkforceReductionsMember2023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:PlantClosingAndOtherMember2023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:WorkforceReductionsMember2024-01-012024-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:PlantClosingAndOtherMember2024-01-012024-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:WorkforceReductionsMember2024-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMemberavnt:PlantClosingAndOtherMember2024-03-310001122976us-gaap:LandAndLandImprovementsMember2024-03-310001122976us-gaap:LandAndLandImprovementsMember2023-12-310001122976us-gaap:BuildingMember2024-03-310001122976us-gaap:BuildingMember2023-12-310001122976us-gaap:MachineryAndEquipmentMember2024-03-310001122976us-gaap:MachineryAndEquipmentMember2023-12-31xbrli:pure0001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2024-03-310001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2024-01-012024-03-310001122976us-gaap:SecuredDebtMemberavnt:SeniorTermLoanDue2029Member2024-03-310001122976us-gaap:SecuredDebtMemberavnt:SeniorTermLoanDue2029Member2024-01-012024-03-310001122976us-gaap:SeniorNotesMemberavnt:A575SeniorNotesDue2025Member2024-03-310001122976us-gaap:SeniorNotesMemberavnt:A575SeniorNotesDue2025Member2024-01-012024-03-310001122976us-gaap:SeniorNotesMemberavnt:A7.125SeniorNotesDue2030Member2024-03-310001122976us-gaap:SeniorNotesMemberavnt:A7.125SeniorNotesDue2030Member2024-01-012024-03-310001122976us-gaap:OtherDebtSecuritiesMember2024-03-310001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2023-12-310001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2023-01-012023-12-310001122976us-gaap:SecuredDebtMemberavnt:SeniorTermLoanDue2029Member2023-12-310001122976us-gaap:SecuredDebtMemberavnt:SeniorTermLoanDue2029Member2023-01-012023-12-310001122976us-gaap:SeniorNotesMemberavnt:A575SeniorNotesDue2025Member2023-12-310001122976us-gaap:SeniorNotesMemberavnt:A575SeniorNotesDue2025Member2023-01-012023-12-310001122976us-gaap:SeniorNotesMemberavnt:A7.125SeniorNotesDue2030Member2023-12-310001122976us-gaap:SeniorNotesMemberavnt:A7.125SeniorNotesDue2030Member2023-01-012023-12-310001122976us-gaap:OtherDebtSecuritiesMember2023-12-310001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:LineOfCreditMember2024-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberavnt:DerivativeInstrumentMaturityPeriodOneMemberus-gaap:NetInvestmentHedgingMember2024-03-31iso4217:EUR0001122976us-gaap:CrossCurrencyInterestRateContractMemberavnt:DerivativeInstrumentMaturityPeriodTwoMemberus-gaap:NetInvestmentHedgingMember2024-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2024-01-012024-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2023-01-012023-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:InterestExpenseMemberus-gaap:NetInvestmentHedgingMember2023-01-012023-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:InterestExpenseMemberus-gaap:NetInvestmentHedgingMember2024-01-012024-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-31avnt:segment0001122976avnt:ColorAdditivesAndInksSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:SegmentContinuingOperationsMember2024-01-012024-03-310001122976avnt:ColorAdditivesAndInksSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:SegmentContinuingOperationsMember2023-01-012023-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsSegmentMemberus-gaap:SegmentContinuingOperationsMember2024-01-012024-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsSegmentMemberus-gaap:SegmentContinuingOperationsMember2023-01-012023-03-310001122976us-gaap:SegmentContinuingOperationsMemberus-gaap:CorporateNonSegmentMember2024-01-012024-03-310001122976us-gaap:SegmentContinuingOperationsMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310001122976us-gaap:SegmentContinuingOperationsMember2024-01-012024-03-310001122976us-gaap:SegmentContinuingOperationsMember2023-01-012023-03-310001122976avnt:ColorAdditivesAndInksSegmentMemberus-gaap:OperatingSegmentsMember2024-03-310001122976avnt:ColorAdditivesAndInksSegmentMemberus-gaap:OperatingSegmentsMember2023-12-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsSegmentMember2024-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsSegmentMember2023-12-310001122976us-gaap:CorporateNonSegmentMember2024-03-310001122976us-gaap:CorporateNonSegmentMember2023-12-3100011229762020-02-29avnt:company0001122976avnt:CalvertCityMember2024-03-310001122976us-gaap:SubsequentEventMemberavnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2024-04-092024-04-090001122976avnt:SecuredOvernightFinancingRateSOFRMemberus-gaap:SubsequentEventMemberavnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2024-04-092024-04-090001122976us-gaap:SubsequentEventMemberavnt:SeniorTermLoanDue2029Memberus-gaap:BaseRateMemberus-gaap:SecuredDebtMember2024-04-092024-04-09


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ________________________________________________
    FORM 10-Q
    ________________________________________________
    (Mark One)
    ☒Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the quarterly period ended March 31, 2024
    OR
     
    ☐Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the transition period from             to             .
    Commission file number 1-16091
     ________________________________________________
    AVIENT CORPORATION
    (Exact name of registrant as specified in its charter)
    ________________________________________________
    Ohio34-1730488
    (State or other jurisdiction(I.R.S. Employer Identification No.)
    of incorporation or organization)
    Avient Center
    33587 Walker Road44012
    Avon Lake, Ohio
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (440) 930-1000
    Former name, former address and former fiscal year, if changed since last report: Not Applicable
    _______________________________________________

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Shares, par value $.01 per shareAVNTNew York Stock Exchange
    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒    Yes   ☐ No
    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒    Yes   ☐ No

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☒Accelerated filer☐
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐  Yes   ☒  No

    The number of the registrant’s outstanding common shares, par value $.01 per share, as of March 31, 2024 was 91,255,268.

    AVIENT CORPORATION


    PART I — FINANCIAL INFORMATION
    ITEM 1. FINANCIAL STATEMENTS
    Avient Corporation
    Condensed Consolidated Statements of Income (Unaudited)
    (In millions, except per share data)
    Three Months Ended
    March 31,
     20242023
    Sales$829.0 $845.7 
    Cost of sales550.8 598.1 
    Gross margin278.2 247.6 
    Selling and administrative expense184.2 190.5 
    Operating income94.0 57.1 
    Interest expense, net(26.6)(28.8)
    Other (expense) income, net(0.9)0.7 
    Income from continuing operations before income taxes66.5 29.0 
    Income tax expense(16.8)(7.7)
    Net income from continuing operations49.7 21.3 
    Loss from discontinued operations, net of income taxes— (0.9)
    Net income$49.7 $20.4 
    Net income attributable to noncontrolling interests(0.3)(0.5)
    Net income attributable to Avient common shareholders$49.4 $19.9 
    Earnings (loss) per share attributable to Avient common shareholders - Basic
    Continuing operations$0.54 $0.23 
    Discontinued operations— (0.01)
    Total$0.54 $0.22 
    Earnings (loss) per share attributable to Avient common shareholders - Diluted
    Continuing operations$0.54 $0.23 
    Discontinued operations— (0.01)
    Total$0.54 $0.22 
    Weighted-average shares used to compute earnings per common share:
    Basic91.2 91.0 
    Dilutive impact of share-based compensation0.8 0.8 
    Diluted92.0 91.8 
    Anti-dilutive shares not included in diluted common shares outstanding1.1 0.5 
    Cash dividends declared per share of common stock$0.2575 $0.2475 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    1 AVIENT CORPORATION


    Avient Corporation
    Consolidated Statements of Comprehensive Income (Unaudited)
    (In millions)
     Three Months Ended
    March 31,
     20242023
    Net income$49.7 $20.4 
    Other comprehensive (loss) income, net of tax:
    Translation adjustments and related hedging instruments(25.9)17.7 
    Other— (1.6)
    Total other comprehensive (loss) income(25.9)16.1 
    Total comprehensive income23.8 36.5 
    Comprehensive income attributable to noncontrolling interests(0.3)(0.5)
    Comprehensive income attributable to Avient common shareholders$23.5 $36.0 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    2 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Balance Sheets
    (In millions)
    (Unaudited) March 31, 2024
    December 31, 2023
    ASSETS
    Current assets:
    Cash and cash equivalents$444.3 $545.8 
    Accounts receivable, net475.3 399.9 
    Inventories, net354.0 347.0 
    Other current assets117.1 114.9 
    Total current assets1,390.7 1,407.6 
    Property, net1,021.7 1,028.9 
    Goodwill1,700.1 1,719.3 
    Intangible assets, net1,546.5 1,590.8 
    Other non-current assets217.1 221.9 
    Total assets$5,876.1 $5,968.5 
    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current liabilities:
    Short-term and current portion of long-term debt$9.6 $9.5 
    Accounts payable428.3 432.3 
    Accrued expenses and other current liabilities294.2 331.8 
    Total current liabilities732.1 773.6 
    Non-current liabilities:
    Long-term debt2,069.4 2,070.5 
    Pension and other post-retirement benefits66.3 67.2 
    Deferred income taxes280.0 281.6 
    Other non-current liabilities390.5 437.6 
    Total non-current liabilities2,806.2 2,856.9 
    SHAREHOLDERS' EQUITY
    Avient shareholders’ equity2,321.3 2,319.2 
    Noncontrolling interest16.5 18.8 
    Total equity2,337.8 2,338.0 
    Total liabilities and equity$5,876.1 $5,968.5 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    3 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Statements of Cash Flows (Unaudited)
    (In millions)
     Three Months Ended
    March 31,
     20242023
    Operating activities
    Net income$49.7 $20.4 
    Adjustments to reconcile net income to net cash used by operating activities:
    Depreciation and amortization43.8 48.7 
    Accelerated depreciation 0.5 1.8 
    Share-based compensation expense3.3 3.2 
    Changes in assets and liabilities:
    Increase in accounts receivable(81.9)(40.2)
    (Increase) decrease in inventories(12.3)3.8 
    Increase (decrease) in accounts payable1.7 (9.9)
    Accrued expenses and other assets and liabilities, net(47.6)(50.0)
    Net cash used by operating activities(42.8)(22.2)
    Investing activities
    Capital expenditures(24.4)(20.3)
    Net proceeds from divestiture— 7.3 
    Proceeds from plant closures2.0 — 
    Other investing activities(2.1)— 
    Net cash used by investing activities(24.5)(13.0)
    Financing activities
    Cash dividends paid(23.5)(22.5)
    Repayment of long-term debt(2.7)(0.8)
    Other financing activities(1.9)(2.3)
    Net cash used by financing activities(28.1)(25.6)
    Effect of exchange rate changes on cash(6.1)2.4 
    Decrease in cash and cash equivalents(101.5)(58.4)
    Cash and cash equivalents at beginning of year545.8 641.1 
    Cash and cash equivalents at end of period$444.3 $582.7 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    4 AVIENT CORPORATION


    Avient Corporation
    Consolidated Statements of Shareholders' Equity (Unaudited)
    (In millions)
     Common SharesShareholders’ Equity
    Common
    Shares
    Common
    Shares Held
    in Treasury
    Common
    Shares
    Additional
    Paid-in
    Capital
    Retained EarningsCommon
    Shares Held
    in Treasury
    Accumulated
    Other
    Comprehensive
    (Loss) Income
    Total Avient Shareholders' EquityNon-controlling InterestsTotal
    Equity
    Balance at January 1, 2024
    122.2 (31.0)$1.2 $1,529.7 $1,808.2 $(932.5)$(87.4)$2,319.2 $18.8 $2,338.0 
    Net income— — — — 49.4 — — 49.4 0.3 49.7 
    Other comprehensive loss— — — — — — (25.9)(25.9)— (25.9)
    Noncontrolling interest activity— — — 0.3 — — 0.3 (2.6)(2.3)
    Cash dividends declared -- $0.2575 per share
    — — — — (23.5)— — (23.5)— (23.5)
    Share-based compensation and exercise of awards— 0.1 — 0.9 — 0.9 — 1.8 — 1.8 
    Balance at March 31, 2024
    122.2 (30.9)$1.2 $1,530.9 $1,834.1 $(931.6)$(113.3)$2,321.3 $16.5 $2,337.8 


     Common SharesShareholders’ Equity
    Common
    Shares
    Common
    Shares  Held
    in Treasury
    Common
    Shares
    Additional
    Paid-in
    Capital
    Retained EarningsCommon
    Shares  Held
    in Treasury
    Accumulated
    Other
    Comprehensive
    (Loss) Income
    Total Avient Shareholders' EquityNon-controlling InterestsTotal
    Equity
    Balance at January 1, 2023
    122.2 (31.3)$1.2 $1,520.5 $1,823.6 $(935.0)$(75.8)$2,334.5 $18.3 $2,352.8 
    Net income— — — — 19.9 — — 19.9 0.5 20.4 
    Other comprehensive income— — — — — — 16.1 16.1 — 16.1 
    Cash dividends declared -- $0.2475 per share
    — — — — (22.5)— — (22.5)— (22.5)
    Share-based compensation and exercise of awards— — — 0.5 — 1.4 — 1.9 — 1.9 
    Balance at March 31, 2023
    122.2 (31.3)$1.2 $1,521.0 $1,820.9 $(933.6)$(59.7)$2,349.8 $18.8 $2,368.6 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    5 AVIENT CORPORATION



    Avient Corporation
    Notes to Condensed Consolidated Financial Statements
    (Unaudited)
    Note 1 — BASIS OF PRESENTATION
    The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Form 10-Q instructions and in the opinion of management contain all adjustments, including those that are normal, recurring and necessary to present fairly the financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. These interim financial statements should be read in conjunction with the financial statements and accompanying notes included in the Annual Report on Form 10-K for the year ended December 31, 2023 of Avient Corporation. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
    Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be attained in subsequent periods or for the year ending December 31, 2024.

    Note 2 — GOODWILL AND INTANGIBLE ASSETS
    Goodwill as of March 31, 2024 and December 31, 2023 and changes in the carrying amount of goodwill by segment were as follows:
    (In millions)Specialty Engineered MaterialsColor, Additives and InksTotal
    Balance at December 31, 2023$682.5 $1,036.8 $1,719.3 
    Currency translation(10.7)(8.5)(19.2)
    Balance at March 31, 2024$671.8 $1,028.3 $1,700.1 

    Indefinite and finite-lived intangible assets consisted of the following:
     As of March 31, 2024
    (In millions)Acquisition CostAccumulated AmortizationCurrency TranslationNet
    Customer relationships$726.2 $(208.7)$12.0 $529.5 
    Patents, technology and other841.8 (223.8)11.7 629.7 
    Indefinite-lived trade names368.0 — 19.3 387.3 
    Total$1,936.0 $(432.5)$43.0 $1,546.5 

     As of December 31, 2023
    (In millions)Acquisition CostAccumulated AmortizationCurrency TranslationNet
    Customer relationships$726.2 $(199.8)$20.0 $546.4 
    Patents, technology and other841.8 (213.1)22.5 651.2 
    Indefinite-lived trade names368.0 — 25.2 393.2 
    Total$1,936.0 $(412.9)$67.7 $1,590.8 



    6 AVIENT CORPORATION


    Note 3 — EMPLOYEE SEPARATION AND RESTRUCTURING COSTS
    We are engaged in a restructuring program associated with our integration of Clariant Color. These actions are expected to enable us to better serve customers, improve efficiency and deliver cost savings. We expect that the full restructuring plan will be implemented by the end of 2025 and anticipate that we will incur approximately $75.0 million of charges in connection with the restructuring plan. As of March 31, 2024, $57.6 million had been incurred.
    A summary of the Clariant Color integration restructuring is shown below:
    (in millions)Workforce reductionsPlant closing and otherTotal
    Balance at January 1, 2023$34.3 $2.4 $36.7 
    Restructuring charges6.9 1.2 8.1 
    Payments, utilization and translation(10.9)(2.8)(13.7)
    Balance at December 31, 2023$30.3 $0.8 $31.1 
    Restructuring charges(2.8)0.1 (2.7)
    Payments, utilization and translation(2.3)(0.1)(2.4)
    Balance at March 31, 2024$25.2 $0.8 $26.0 

    Note 4 — INVENTORIES, NET
    Components of Inventories, net are as follows:
    (In millions)As of March 31, 2024As of December 31, 2023
    Finished products$151.5 $166.0 
    Work in process32.6 19.8 
    Raw materials and supplies169.9 161.2 
    Inventories, net$354.0 $347.0 

    Note 5 — PROPERTY, NET
    Components of Property, net are as follows:
    (In millions)As of March 31, 2024As of December 31, 2023
    Land and land improvements$95.7 $98.5 
    Buildings435.0 439.8 
    Machinery and equipment1,393.0 1,381.1 
    Property, gross1,923.7 1,919.4 
    Less accumulated depreciation(902.0)(890.5)
    Property, net$1,021.7 $1,028.9 

    Note 6 — INCOME TAXES
    During the three months ended March 31, 2024, the Company’s effective tax rate of 25.3% was above the U.S. federal statutory rate of 21.0% primarily due to foreign withholding tax, tax on global intangible low-taxed income (GILTI), non-deductible items, and an increase in foreign valuation allowances. These unfavorable items were partially offset by U.S. research and development credits.
    During the three months ended March 31, 2023, the Company’s effective tax rate of 26.6% was above the U.S. federal statutory rate of 21.0% primarily due to foreign withholding tax, tax on GILTI, non-deductible items, and an increase in foreign valuation allowances. These unfavorable items were partially offset by U.S. research and development credits, favorable foreign earnings mix, and permanent items.


    7 AVIENT CORPORATION


    Note 7 — FINANCING ARRANGEMENTS
    Debt consists of the following instruments:
    As of March 31, 2024 (in millions)Principal AmountUnamortized discount and debt issuance costNet DebtWeighted average interest rate
    Senior secured revolving credit facility due 2026$— $— $— — %
    Senior secured term loan due 2029726.1 18.0 708.1 7.86 %
    5.75% senior notes due 2025
    650.0 2.3 647.7 5.75 %
    7.125% senior notes due 2030
    725.0 8.5 716.5 7.125 %
    Other Debt6.7 — 6.7 
    Total Debt2,107.8 28.8 2,079.0 
    Less short-term and current portion of long-term debt9.6 — 9.6 
    Total long-term debt, net of current portion$2,098.2 $28.8 $2,069.4 

    As of December 31, 2023 (in millions)Principal AmountUnamortized discount and debt issuance costNet DebtWeighted average interest rate
    Senior secured revolving credit facility due 2026$— $— $— — %
    Senior secured term loan due 2029727.9 18.9 709.0 7.88 %
    5.75% senior notes due 2025
    650.0 2.8 647.2 5.75 %
    7.125% senior notes due 2030
    725.0 8.8 716.2 7.125 %
    Other Debt7.6 — 7.6 
    Total Debt2,110.5 30.5 2,080.0 
    Less short-term and current portion of long-term debt9.5 — 9.5 
    Total long-term debt, net of current portion$2,101.0 $30.5 $2,070.5 
    As of March 31, 2024, we had no borrowings outstanding under our senior secured revolving credit facility due 2026 (Revolving Credit Facility), which had remaining availability of $250.5 million.
    The agreements governing our Revolving Credit Facility and our senior secured term loan, and the indentures and credit agreements governing other debt contain a number of customary financial and restrictive covenants that, among other things, limit our ability to: sell or otherwise transfer assets, including in a spin-off, incur additional debt or liens, consolidate or merge with any entity or transfer or sell all or substantially all of our assets, pay dividends or make certain other restricted payments, make investments, enter into transactions with affiliates, create dividend or other payment restrictions with respect to subsidiaries, make capital investments and alter the business we conduct. As of March 31, 2024, we were in compliance with all covenants.
    The estimated fair value of Avient’s debt instruments at March 31, 2024 and December 31, 2023 was $2,092.8 million and $2,113.7 million, respectively. The fair value of Avient’s debt instruments was estimated using prevailing market interest rates on debt with similar creditworthiness, terms and maturities and represent Level 2 measurements within the fair value hierarchy.
    Note 8 — DERIVATIVES AND HEDGING
    We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. We formally assess, designate and document, as a hedge of an underlying exposure, the qualifying derivative instrument that will be accounted for as an accounting hedge at inception. Additionally, we assess both at inception and at least quarterly thereafter, whether the financial instruments used in the hedging transaction are effective at offsetting changes in either the fair values or cash flows of the underlying exposures. In accordance with ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12), that ongoing assessment will be done qualitatively for highly effective relationships.

    8 AVIENT CORPORATION


    As a means of mitigating the impact of currency fluctuations on our euro investments in foreign entities, we have executed cross currency swaps, in which we pay fixed-rate interest in euros and receive fixed-rate interest in U.S. dollars related to our future obligations to exchange euros for U.S. dollars. These cross currency swaps effectively convert a portion of our U.S. dollar denominated fixed-rate debt to euro denominated fixed-rate debt.
    We currently hold cross currency swaps with a combined notional amount of €1,467.2 million, maturing in May 2025 and €900.0 million maturing in August 2027. We designated the cross currency swaps as net investment hedges of our net investment in our European operations under ASU 2017-12 and applied the spot method to these hedges. The changes in fair value of the derivative instruments that are designated and qualify as hedges of net investments in foreign operations are recognized within Accumulated Other Comprehensive (Loss) Income (AOCI) to offset the changes in the values of the net investment being hedged. For the three months ended March 31, 2024, a gain of $35.3 million was recognized within translation adjustments in AOCI, net of tax, compared to losses of $29.5 million, net of tax, for the three months ended March 31, 2023. Included in Interest expense, net within the Condensed Consolidated Statements of Income are benefits of $9.7 million for the three months ended March 31, 2024 and 2023, associated with the cross currency swaps.
    All of our derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. We determine the fair value of our derivatives based on valuation methods, which project future cash flows and discount the future amounts to present value using market based observable inputs, including interest rate curves and foreign currency rates.
    The fair value of derivative financial instruments recognized in the Condensed Consolidated Balance Sheets is as follows:
    (In millions)Balance Sheet Location
    As of
    March 31, 2024
    As of
    December 31, 2023
    Cross Currency Swaps (Net Investment Hedge)
    Other non-current liabilities$152.6 $199.1 
    Note 9 — SEGMENT INFORMATION
    Avient has two reportable segments: (1) Color, Additives and Inks and (2) Specialty Engineered Materials. Operating income is the primary measure that is reported to our chief operating decision maker (CODM) for purposes of allocating resources to the segments and assessing their performance. Operating income at the segment level does not include: corporate general and administrative expenses that are not allocated to segments; intersegment sales and profit eliminations; charges related to specific strategic initiatives, such as the consolidation of operations; restructuring activities, including employee separation costs resulting from personnel reduction programs, plant closure and phase-in costs; costs incurred directly in relation to acquisitions or divestitures; integration costs; executive separation agreements; share-based compensation costs; asset impairments; environmental remediation costs, along with related gains from insurance recoveries, and other liabilities for facilities no longer owned or closed in prior years; actuarial gains and losses associated with our pension and other post-retirement benefit plans; and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
    Financial information by reportable segment is as follows:
     Three Months Ended March 31, 2024Three Months Ended March 31, 2023
    (In millions)SalesOperating
    Income
    SalesOperating
    Income
    Color, Additives and Inks$515.3 $74.8 $537.0 $65.6 
    Specialty Engineered Materials314.4 53.4 309.7 43.1 
    Corporate (0.7)(34.2)(1.0)(51.6)
    Total$829.0 $94.0 $845.7 $57.1 
     Total Assets
    (In millions)As of March 31, 2024As of December 31, 2023
    Color, Additives and Inks$2,664.5 $2,657.2 
    Specialty Engineered Materials2,537.7 2,532.6 
    Corporate673.9 778.7 
    Total assets$5,876.1 $5,968.5 

    9 AVIENT CORPORATION


    Note 10 — COMMITMENTS AND CONTINGENCIES
    We have been notified by federal and state environmental agencies and by private parties that we may be a potentially responsible party (PRP) in connection with the environmental investigation and remediation of certain sites. While government agencies frequently assert that PRPs are jointly and severally liable at these sites, in our experience, the interim and final allocations of liability costs are generally made based on the relative contribution of waste. We may also initiate corrective and preventive environmental projects of our own to support safe and lawful activities at our operations. We believe that compliance with current governmental regulations at all levels will not have a material adverse effect on our financial position, results of operations or cash flows.
    In September 2007, the United States District Court for the Western District of Kentucky (Court) in the case of Westlake Vinyls, Inc. v. Goodrich Corporation, et al., held that Avient must pay the remediation costs at the former Goodrich Corporation Calvert City facility (now largely owned and operated by Westlake Vinyls, Inc. (Westlake Vinyls)), together with certain defense costs of Goodrich Corporation. The rulings also provided that Avient can seek indemnification for contamination attributable to Westlake Vinyls.
    Following the rulings, the parties to the litigation agreed to settle all claims regarding past environmental costs incurred at the site. The settlement agreement provides a mechanism to pursue allocation of future remediation costs at the Calvert City site to Westlake Vinyls. We continue to pursue available insurance coverage related to this matter and are in current litigation to recover previously incurred costs. It is reasonably possible that insurance recoveries could result in a material benefit to our Condensed Consolidated Statements of Income in a future period, though the amounts, if any, nor the timing are currently known.
    The environmental obligation at the site arose as a result of an agreement between The B.F. Goodrich Company (n/k/a Goodrich Corporation) and our predecessor, The Geon Company, at the time of the initial public offering in 1993. Under the agreement, The Geon Company agreed to indemnify Goodrich Corporation for certain environmental costs at the site. Neither Avient nor The Geon Company ever operated the facility.
    Since 2009, Avient, along with respondents Westlake Vinyls, and Goodrich Corporation, has worked with the United States Environmental Protection Agency (USEPA) to address the remedial activities at the site. The USEPA issued its Record of Decision (ROD) in September 2018. In April 2019, the respondents signed an Administrative Settlement Agreement and Order on Consent with the USEPA to conduct the remedial actions at the site. In February 2020, three companies signed the agreed Consent Decree and remedial action Work Plan, which received Federal Court approval in January 2021. In August 2023, the Company received construction bids for components of the remedial action and we updated our accruals to align to the selected bid costs. We are currently in the process of remedial action for a portion of the site, while continuing to progress through remedial design for other portions of the site. As we have progressed through remedial design and action, additional charges have been recognized to reflect the actual costs of completion. As of March 31, 2024, we had accrued $143.7 million for this matter.
    Total environmental accruals of $151.7 million and $157.2 million are reflected within Accrued expenses and other current liabilities and Other non-current liabilities in our Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023, respectively. These undiscounted accruals represent our best estimate of probable future costs that we can reasonably estimate, based upon currently available information and technology and how the remedy will be implemented. It is reasonably possible that we could incur additional costs in excess of the amount accrued, which could be material to our Condensed Consolidated Statements of Income. However, such additional costs cannot be currently estimated as they are dependent upon the results of future testing and findings during the execution of remedial design and remedial action, the ultimate remedial action undertaken, changes in regulations, technology development, new information, newly discovered conditions and other factors that are not currently known.
    During the three months ended March 31, 2024, Avient recognized $4.0 million related to environmental remediation costs, compared to $1.4 million recognized during the three months ended March 31, 2023. These costs are recognized in Cost of Sales within the Condensed Consolidated Statements of Income.
    Avient is subject to a broad range of claims, administrative and legal proceedings such as lawsuits that relate to contractual allegations, tax audits, product claims, personal injuries, and employment related matters. Although it is not possible to predict with certainty the outcome or cost of these matters, the Company believes our current reserves are appropriate and these matters will not have a material adverse effect on the condensed consolidated financial statements.


    10 AVIENT CORPORATION


    Note 11 — SUBSEQUENT EVENTS
    On April 9, 2024, the Company refinanced its senior secured term loan by amending the credit agreement governing such term loan (the "Term Loan Amendment"). The amendment reduced the interest rates per annum by 50 basis points, which are now either (i) Adjusted Term SOFR (as defined in the Term Loan Amendment) plus 2.00%, or (ii) a Base Rate (as defined in the Term Loan Amendment) plus 1.00%. The other terms and conditions, including the maturity date, that apply to the amended term loan are substantially the same as the terms and conditions that applied to the existing term loans under the credit agreement immediately prior to the Term Loan Amendment.

    11 AVIENT CORPORATION


    ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    Our Business
    We are a premier formulator of specialized and sustainable materials solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Our products include specialty engineered materials, performance fibers, advanced composites, and color and additive systems. We are also a highly specialized developer and manufacturer of performance enhancing additives, liquid colorants and silicone colorants. Headquartered in Avon Lake, Ohio, we have manufacturing and warehouses across the globe. We provide value to our customers through our ability to link our knowledge of polymers and formulation technology with our manufacturing and supply chain capabilities to provide value-added solutions to designers, assemblers and processors of plastics. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
    Results of Operations — The three months ended March 31, 2024 compared to three months ended March 31, 2023:
     Three Months Ended March 31,Variances — Favorable (Unfavorable)
    (Dollars in millions, except per share data)20242023Change%
    Change
    Sales$829.0 $845.7 $(16.7)(2.0)%
    Cost of sales550.8 598.1 47.3 7.9 %
    Gross margin278.2 247.6 30.6 12.4 %
    Selling and administrative expense184.2 190.5 6.3 3.3 %
    Operating income94.0 57.1 36.9 64.6 %
    Interest expense, net(26.6)(28.8)2.2 7.6 %
    Other (expense) income, net(0.9)0.7 (1.6)nm
    Income from continuing operations before income taxes66.5 29.0 37.5 129.3 %
    Income tax expense(16.8)(7.7)(9.1)nm
    Net income from continuing operations49.7 21.3 28.4 133.3 %
    Loss from discontinued operations, net of income taxes— (0.9)0.9 nm
    Net income49.7 20.4 29.3 143.6 %
    Net income attributable to noncontrolling interests(0.3)(0.5)0.2 nm
    Net income attributable to Avient common shareholders$49.4 $19.9 $29.5 148.2 %
    Earnings (loss) per share attributable to Avient common shareholders - Basic
    Continuing operations$0.54 $0.23 
    Discontinued operations— (0.01)
    Total$0.54 $0.22 
    Earnings (loss) per share attributable to Avient common shareholders - Diluted
    Continuing operations$0.54 $0.23 
    Discontinued operations— (0.01)
    Total$0.54 $0.22 
    nm - not meaningful
    Sales
    Sales decreased $16.7 million or 2.0% in the three months ended March 31, 2024 compared to the three months ended March 31, 2023, primarily driven by lower sales in Europe, partially offset by increased demand in the defense end market.

    12 AVIENT CORPORATION


    Gross Margin
    Gross margin as a percentage of sales was 33.6% for the three months ended March 31, 2024 compared to 29.3% for the three months ended March 31, 2023. The gross margin improvement was driven primarily by the benefit from raw material deflation, lower restructuring charges and mix improvement.
    Selling and administrative expense
    Selling and administrative expense decreased $6.3 million during the three months ended March 31, 2024 compared to the three months ended March 31, 2023, primarily driven by lower restructuring charges which were partially offset by increased employee costs.
    Interest expense, net
    Interest expense, net decreased $2.2 million in the three months ended March 31, 2024 compared to the three months ended March 31, 2023, primarily driven by the partial principal prepayment and refinancing of our senior secured term loans during the third quarter of 2023.
    Income taxes
    During the three months ended March 31, 2024, the Company’s effective tax rate was 25.3% versus 26.6% for the three months ended March 31, 2023. The income tax rate decrease is primarily due to the lower tax expense associated with valuation allowances partially offset by unfavorable rate impacts associated with foreign earnings mix and permanent items for the three months ended March 31, 2024 compared to the three months ended March 31, 2023.
    SEGMENT INFORMATION
    Avient has two reportable segments: (1) Color, Additives and Inks; and (2) Specialty Engineered Materials.
    Operating income is the primary measure that is reported to our chief operating decision maker (CODM) for purposes of allocating resources to the segments and assessing their performance. Operating income at the segment level does not include: corporate general and administrative costs that are not allocated to segments; intersegment sales and profit eliminations; charges related to specific strategic initiatives, such as the consolidation of operations; restructuring activities, including employee separation costs resulting from personnel reduction programs, plant closure and phase-in costs; costs incurred directly in relation to acquisitions or divestitures; integration costs; executive separation agreements; share-based compensation costs; asset impairments; environmental remediation costs, along with related gains from insurance recoveries, and other liabilities for facilities no longer owned or closed in prior years; actuarial gains and losses associated with our pension and other post-retirement benefit plans; and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
    Sales and Operating Income — The three months ended March 31, 2024 compared to the three months ended March 31, 2023: 
     Three Months Ended March 31,Variances — Favorable
    (Unfavorable)
    (Dollars in millions)20242023Change%
    Change
    Sales:
    Color, Additives and Inks$515.3 $537.0 $(21.7)(4.0)%
    Specialty Engineered Materials
    314.4 309.7 4.7 1.5 %
    Corporate(0.7)(1.0)0.3 nm
    Total sales$829.0 $845.7 $(16.7)(2.0)%
    Operating income:
    Color, Additives and Inks$74.8 $65.6 $9.2 14.0 %
    Specialty Engineered Materials
    53.4 43.1 10.3 23.9 %
    Corporate(34.2)(51.6)17.4 33.7 %
    Total operating income$94.0 $57.1 $36.9 64.6 %
    nm - not meaningful

    13 AVIENT CORPORATION


    Color, Additives and Inks
    Sales decreased $21.7 million, or 4.0%, in the three months ended March 31, 2024 compared to the three months ended March 31, 2023, driven by lower demand, primarily in Europe.
    Operating income increased $9.2 million, or 14.0%, in the three months ended March 31, 2024 compared to the three months ended March 31, 2023, primarily due to benefits from raw material deflation, which more than offset lower European demand.
    Specialty Engineered Materials
    Sales increased $4.7 million, or 1.5%, in the three months ended March 31, 2024 compared to the three months ended March 31, 2023, primarily driven by increased demand for defense applications, which was partially offset by demand weakness in the telecommunications end market and unfavorable foreign exchange rates, which had an impact of 0.7%
    Operating income increased $10.3 million, or 23.9%, in the three months ended March 31, 2024 as compared to the three months ended March 31, 2023, primarily due to increased demand noted above, mix improvement and benefits from raw material deflation.
    Corporate
    Corporate costs decreased $17.4 million, or 33.7%, in the three months ended March 31, 2024 as compared to the three months ended March 31, 2023 primarily due to $20.8 million of lower restructuring charges.
    Liquidity and Capital Resources
    Our objective is to finance our business through operating cash flow and an appropriate mix of debt and equity. By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. We may from time to time seek to retire or purchase our outstanding debt with cash and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise. We may also seek to repurchase our outstanding common shares. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved have been and may continue to be material.
    The following table summarizes our liquidity as of March 31, 2024 and December 31, 2023:
    (In millions)As of March 31, 2024As of December 31, 2023
    Cash and cash equivalents$444.3 $545.8 
    Revolving credit availability250.5 199.7 
    Liquidity$694.8 $745.5 

    As of March 31, 2024, approximately 77% of the Company’s cash and cash equivalents resided outside the United States.
    Expected sources of cash needed to satisfy cash requirements for 2024 include our cash on hand, cash from operations and available liquidity under our revolving credit facility, if necessary. We believe that these sources will provide sufficient liquidity to satisfy our expected uses of cash for at least the next twelve months and the foreseeable future thereafter. Expected uses of cash for 2024 include interest payments, cash taxes, dividend payments, environmental remediation costs and capital expenditures.
    Cash Flows
    The following describes the significant components of cash flows from operating, investing and financing activities for the three months ended March 31, 2024 and 2023.
    Operating Activities — Net cash used by operating activities increased $20.6 million during the three months ended March 31, 2024 compared to the three months ended March 31, 2023 as a $43.8 million investment in working capital was partially offset by $29.3 million of higher earnings.
    Investing Activities — Net cash used by investing activities during the three months ended March 31, 2024 of $24.5 million primarily reflects the impact of capital expenditures.
    Net cash used by investing activities during the three months ended March 31, 2023 of $13.0 million reflects the impact of capital expenditures of $20.3 million, offset by proceeds received from the divestiture of the Distribution business of $7.3 million.

    14 AVIENT CORPORATION


    Financing Activities — Net cash used by financing activities for the three months ended March 31, 2024 of $28.1 million primarily reflects $23.5 million of dividends paid.
    Net cash used by financing activities for the three months ended March 31, 2023 of $25.6 million primarily reflects $22.5 million of dividends paid.
    Debt
    As of March 31, 2024, our principal amount of debt totaled $2,107.8 million. Aggregate maturities of the principal amount of debt for the current year, next four years and thereafter, are as follows:
    (In millions)
    2024$6.8 
    2025659.6 
    20267.8 
    20277.7 
    20287.7 
    Thereafter1,418.2 
    Aggregate maturities$2,107.8 
    As of March 31, 2024, we were in compliance with all financial and restrictive covenants pertaining to our debt. For additional information regarding our debt, please see Note 7, Financing Arrangements to the accompanying condensed consolidated financial statements.
    Derivatives and Hedging
    We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. For additional information regarding our derivative instruments, please see Note 8, Derivatives and Hedging to the accompanying condensed consolidated financial statements.
    Material Cash Requirements
    We have future obligations under various contracts relating to debt and interest payments, operating leases, pension and post-retirement benefit plans and purchase obligations. During the three months ended March 31, 2024, there were no material changes to these obligations as reported in our Annual Report on Form 10-K for the year ended December 31, 2023.


    15 AVIENT CORPORATION


    CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
    In this Quarterly Report on Form 10-Q, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historic or current facts. They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
    •disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
    •the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
    •disruptions or inefficiencies in our supply chain, logistics, or operations;
    •changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
    •fluctuations in raw material prices, quality and supply, and in energy prices and supply;
    •demand for our products and services;
    •production outages or material costs associated with scheduled or unscheduled maintenance programs;
    •unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
    •our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
    •information systems failures and cyberattacks;
    •amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
    •our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning (ERP) system, S/4HANA;
    •other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, and any recessionary conditions; and
    •other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023 under Item 1A, “Risk Factors.”
    We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the Securities and Exchange Commission. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.

    16 AVIENT CORPORATION


    ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
    There have been no material changes to exposures to market risk as reported in our Annual Report on Form 10-K for the year ended December 31, 2023.

    ITEM 4.
    CONTROLS AND PROCEDURES
    Disclosure controls and procedures
    Avient’s management, under the supervision of and with the participation of its Chief Executive Officer and its Chief Financial Officer, has evaluated the effectiveness of the design and operation of Avient’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report. Based upon this evaluation, Avient’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report, its disclosure controls and procedures were effective.
    Changes in internal control over financial reporting
    There were no changes in Avient’s internal control over financial reporting during the quarter ended March 31, 2024 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

    PART II — OTHER INFORMATION
    ITEM 1. LEGAL PROCEEDINGS
    Information regarding certain legal proceedings can be found in Note 10, Commitments and Contingencies to the accompanying condensed consolidated financial statements and is incorporated by reference herein.

    ITEM 1A.
     RISK FACTORS
    We face a number of risks that could adversely affect our business, results of operations, financial position or cash flows. A discussion of our risk factors can be found in Item 1A, Risk factors, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. During the three months ended March 31, 2024, there were no material changes to our previously disclosed risk factors.

    ITEM 2.
     UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
    The table below sets forth information regarding the repurchase of shares of our common shares during the period indicated.
    PeriodTotal Number of Shares PurchasedWeighted Average Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Program
    Maximum Number of Shares that May Yet be Purchased Under the Program (1)
    January 1 to January 31— $— — 4,957,472 
    February 1 to February 29— — — 4,957,472 
    March 1 to March 31— — — 4,957,472 
    Total— $— — 
    (1) Our Board of Directors approved a common share repurchase program authorizing Avient to purchase its common shares in August 2008, which share repurchase authorization has been subsequently increased from time to time. On December 9, 2020, we announced that we would increase our share buyback by an additional 5.0 million shares. As of March 31, 2024, approximately 5.0 million shares remained available for purchase under these authorizations, which have no expiration. Purchases of common shares may be made by open market purchases or privately negotiated transactions and may be made pursuant to Rule 10b5-1 plans and accelerated share repurchases.

    17 AVIENT CORPORATION


    ITEM 5. OTHER INFORMATION
    Trading Arrangements
    None of the Company's directors or officers (as defined in Rule 16a-1(f) promulgated under the Securities Exchange Act of 1934) adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the Company's fiscal quarter ended March 31, 2024.
    Named Executive Officer Retirement
    Consistent with the Company's prior disclosure in a Current Report on Form 8-K filed on November 13, 2023, Robert M. Patterson, the Company's former Chief Executive Officer (and currently a Special Advisor to the Company), is expected to cease serving as an employee of the Company on May 31, 2024. On May 3, 2024, in connection with Mr. Patterson's departure, the Compensation Committee of the Board of Directors approved continued vesting treatment for all of Mr. Patterson's outstanding long-term incentive awards, in exchange for a release of claims from Mr. Patterson, agreement by Mr. Patterson to provide post-employment assistance to and cooperation with the Company, and an extension of Mr. Patterson's post-employment non-competition and non-solicitation covenants for an additional year.

    18 AVIENT CORPORATION


    ITEM 6. EXHIBITS
    EXHIBIT INDEX
    Exhibit No.Exhibit Description
    3.1
    Amended and Restated Articles of Incorporation of Avient Corporation (as amended through June 30, 2020) (incorporated by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, SEC File No. 1-16091)
    3.2
    Avient Corporation Regulations (amended and restated effective May 11, 2023) (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K, filed May 16, 2023, SEC File No. 1-16091)
    10.1†**
    Amendment Agreement No. 9, dated as of April 9, 2024, by and among Avient Corporation, the other Loan Parties party hereto, the existing Lenders under, and as defined in, the Credit Agreement party thereto, and Citibank, N.A., as the administrative agent and as the Amendment No. 9 Additional Term Lender
    31.1**
    Certification of Ashish K. Khandpur, President and Chief Executive Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    31.2**
    Certification of Jamie A. Beggs, Senior Vice President and Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    32.1*
    Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Ashish K. Khandpur, President and Chief Executive Officer
    32.2*
    Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Jamie A. Beggs, Senior Vice President and Chief Financial Officer
    101.INSInline XBRL Instance Document
    101.SCHInline XBRL Taxonomy Extension Schema Document
    101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
    101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
    101.LABInline XBRL Taxonomy Extension Label Linkbase Document
    101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
    104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
    †
    Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided to the Securities and Exchange Commission upon request.
    *Furnished herewith.
    **Filed herewith.

    19 AVIENT CORPORATION


    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
    May 7, 2024AVIENT CORPORATION
    /s/ Jamie A. Beggs
    Jamie A. Beggs
    Senior Vice President and Chief Financial Officer


    20 AVIENT CORPORATION
    Get the next $AVNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVNT

    DatePrice TargetRatingAnalyst
    9/17/2025$48.00Overweight
    KeyBanc Capital Markets
    3/14/2025$43.00Neutral
    Robert W. Baird
    2/18/2025$56.00Neutral → Buy
    Seaport Research Partners
    10/18/2024Buy → Neutral
    Seaport Research Partners
    8/7/2024$49.00 → $52.00Hold → Buy
    Deutsche Bank
    11/6/2023$46.00 → $37.00Buy → Hold
    Deutsche Bank
    2/16/2023$50.00Perform → Outperform
    Oppenheimer
    10/17/2022$40.00Buy
    Deutsche Bank
    More analyst ratings

    $AVNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, President CAI Moh Woon Keat exercised 1,870 shares at a strike of $24.98 and covered exercise/tax liability with 1,618 shares, increasing direct ownership by 2% to 12,807 units (SEC Form 4)

    4 - AVIENT CORP (0001122976) (Issuer)

    1/22/26 2:20:33 PM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form 4 filed by SVP, Global Supply Chain Rizzo Aniello

    4 - AVIENT CORP (0001122976) (Issuer)

    1/21/26 2:48:55 PM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form 3 filed by new insider Rizzo Aniello

    3 - AVIENT CORP (0001122976) (Issuer)

    1/21/26 1:36:31 PM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avient Announces Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance

    Fourth quarter sales increased 2% to $761 million and full-year sales increased 1% to $3,260 million; foreign exchange had a favorable sales impact of 3% on the fourth quarter and 1% for the full yearFourth quarter and full-year GAAP EPS of $0.18 and $0.89 compared to $0.52 and $1.84 in the prior year  Fourth quarter adjusted EPS of $0.56 represents 14% growth over the prior year quarter primarily driven by organic sales growth in the Specialty Engineered Materials segment and company-wide productivity initiatives2025 full-year adjusted EPS of $2.82 represents an increase of 6% over the prior year, driven by adjusted EBITDA margin expansion of 50 bps to 16.7% and lower interest expenseStrong

    2/12/26 6:17:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient To Hold Fourth Quarter 2025 Conference Call

    CLEVELAND, Jan. 7, 2026 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, intends to release its fourth quarter 2025 earnings before the market opens on Thursday, February 12, 2026. The company will then host a webcast with a slide presentation at 8:00 a.m. Eastern Time on Thursday, February 12, 2026. The webcast can be viewed live at avient.com/investors, or by clicking on the webcast link here. Conference call participants in the question and answer session should pre-register using the link at avient.com/investors, or here, to receive the

    1/7/26 7:00:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient Announces Third Quarter 2025 Results

    Third quarter sales of $807 million, 1% below the prior year quarter and includes a favorable impact of 2% from foreign exchangeThird quarter GAAP EPS of $0.36 compared to $0.41 in the prior year quarterThird quarter adjusted EPS of $0.70 in line with prior guidance; represents 8% growth over the prior year quarter, driven by EBITDA margin expansion in both business segments, as well as lower interest and tax expenseMaintaining 2025 full-year adjusted EPS guidance range of $2.77 to $2.87 reflecting 4% to 8% year-over-year growthStrong cash flow generation in the quarter supported $50 million of additional debt repayment bringing year-to-date total to $100 million; expecting total debt repaym

    11/5/25 6:15:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets initiated coverage on Avient with a new price target

    KeyBanc Capital Markets initiated coverage of Avient with a rating of Overweight and set a new price target of $48.00

    9/17/25 7:58:06 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Robert W. Baird initiated coverage on Avient with a new price target

    Robert W. Baird initiated coverage of Avient with a rating of Neutral and set a new price target of $43.00

    3/14/25 7:30:35 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Avient from Neutral to Buy and set a new price target of $56.00

    2/18/25 7:06:32 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    SEC Filings

    View All

    Avient Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AVIENT CORP (0001122976) (Filer)

    2/12/26 6:01:28 AM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Avient Corporation

    10-Q - AVIENT CORP (0001122976) (Filer)

    11/5/25 1:12:02 PM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AVIENT CORP (0001122976) (Filer)

    11/5/25 6:01:41 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Patterson Robert M bought $839,589 worth of shares (24,304 units at $34.55), increasing direct ownership by 4% to 610,897 units (SEC Form 4)

    4 - AVIENT CORP (0001122976) (Issuer)

    11/20/23 7:22:34 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Financials

    Live finance-specific insights

    View All

    Avient Announces Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance

    Fourth quarter sales increased 2% to $761 million and full-year sales increased 1% to $3,260 million; foreign exchange had a favorable sales impact of 3% on the fourth quarter and 1% for the full yearFourth quarter and full-year GAAP EPS of $0.18 and $0.89 compared to $0.52 and $1.84 in the prior year  Fourth quarter adjusted EPS of $0.56 represents 14% growth over the prior year quarter primarily driven by organic sales growth in the Specialty Engineered Materials segment and company-wide productivity initiatives2025 full-year adjusted EPS of $2.82 represents an increase of 6% over the prior year, driven by adjusted EBITDA margin expansion of 50 bps to 16.7% and lower interest expenseStrong

    2/12/26 6:17:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient To Hold Fourth Quarter 2025 Conference Call

    CLEVELAND, Jan. 7, 2026 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, intends to release its fourth quarter 2025 earnings before the market opens on Thursday, February 12, 2026. The company will then host a webcast with a slide presentation at 8:00 a.m. Eastern Time on Thursday, February 12, 2026. The webcast can be viewed live at avient.com/investors, or by clicking on the webcast link here. Conference call participants in the question and answer session should pre-register using the link at avient.com/investors, or here, to receive the

    1/7/26 7:00:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    Avient Announces Third Quarter 2025 Results

    Third quarter sales of $807 million, 1% below the prior year quarter and includes a favorable impact of 2% from foreign exchangeThird quarter GAAP EPS of $0.36 compared to $0.41 in the prior year quarterThird quarter adjusted EPS of $0.70 in line with prior guidance; represents 8% growth over the prior year quarter, driven by EBITDA margin expansion in both business segments, as well as lower interest and tax expenseMaintaining 2025 full-year adjusted EPS guidance range of $2.77 to $2.87 reflecting 4% to 8% year-over-year growthStrong cash flow generation in the quarter supported $50 million of additional debt repayment bringing year-to-date total to $100 million; expecting total debt repaym

    11/5/25 6:15:00 AM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Avient Corporation (Amendment)

    SC 13G/A - AVIENT CORP (0001122976) (Subject)

    2/13/24 4:58:57 PM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Avient Corporation (Amendment)

    SC 13G/A - AVIENT CORP (0001122976) (Subject)

    2/9/24 7:50:56 AM ET
    $AVNT
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Avient Corporation

    SC 13G - AVIENT CORP (0001122976) (Subject)

    3/1/23 1:24:32 PM ET
    $AVNT
    Major Chemicals
    Industrials

    $AVNT
    Leadership Updates

    Live Leadership Updates

    View All

    Avient Board of Directors Appoints Ashish K. Khandpur as Chairman of the Board

    CLEVELAND, May 14, 2025 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, today announced that its Board of Directors has appointed Ashish K. Khandpur, Ph.D., Avient's President, Chief Executive Officer and Director, to serve in the additional role of Chairman of the Board, effective May 14, 2025. Dr. Khandpur succeeds Richard H. Fearon, who had served as Chairman of the Board of Directors since December 2023 and will continue to serve on the Board.  "Since joining Avient, Ashish has made an immediate impact, effectively leading the company i

    5/14/25 4:30:00 PM ET
    $AVNT
    Major Chemicals
    Industrials

    Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

    Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

    6/26/24 8:00:00 AM ET
    $A
    $ANIK
    $AVNT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Medical/Dental Instruments
    Health Care

    International Paper Announces Changes to Its Board of Directors

     Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

    5/23/24 10:51:00 AM ET
    $ALB
    $AVNT
    $IP
    Major Chemicals
    Industrials
    Paper
    Basic Materials